Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Retinoblastoma 22Unspecified Adult Solid Tumor, Protocol Specific 5Sarcoma 4Medulloblastoma 4Central Nervous System Neoplasms 4Rhabdoid Tumor 3Retinal Neoplasms 3Optic Nerve Glioma 3Neuroblastoma 3Carcinoma, Renal Cell 3Astrocytoma 3Wilms Tumor 2Relapsed Pediatric Solid Tumor 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms 2Melanoma 2Hepatoblastoma 2Familial ependymoma 2Extensive Stage Small Cell Lung Cancer 2Choroid Plexus Neoplasms 2Advanced Solid Tumors 2Uveal Melanoma 1Urologic Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Unresectable Locally Advanced or Metastatic Solid Tumors 1Thyroid Neoplasms 1Thrombocytopenia 1Testicular Neoplasms 1Solid Tumor 1Small Cell Lung Carcinoma 1

Interventions

pazopanib 2Ifosfamide 2Etoposide 2Carboplatin 2vandetanib 1ruxolitinib 1fludarabine 1Vemurafenib 1Trastuzumab 1Sorafenib 1Imatinib Mesylate 1Everolimus 1Erlotinib Hydrochloride 1Dasatinib 1Cytarabine 1Crizotinib 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Relapsed Pediatric Solid Tumor × Etoposide × Other solid neoplasm × Clear all
NCT02638428 2020-03-19

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

Samsung Medical Center

Phase 2 Unknown
90 enrolled
Other solid neoplasm

Relapsed Pediatric Solid Tumor

NCT03628131 2018-09-19

Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors

Samsung Medical Center

Phase 1/2 Unknown
46 enrolled
Other solid neoplasm

Relapsed Pediatric Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡